Atmo Biosciences is a revolutionary brand that offers the world's first ingestible gas-sensing capsule, known as the Atmo® Gas Capsule. This innovative capsule provides unique insights into gut health and microbiome function, aiming to revolutionize the diagnosis and treatment of various gut disorders. The Gas Capsule assesses the functional health of a patient's entire gastrointestinal system, offering better diagnosis, personalized treatment, earlier relief of symptoms, and improved healthcare outcomes.

It electronically detects gases and wirelessly transmits data, providing valuable insights into the location of the capsule, microbiome function, and gastrointestinal health. This vitamin-sized electronic Lab-in-a-Pill measures gaseous biomarkers at the source of production within the gastrointestinal system. The data is continuously transmitted to a pocket-sized receiver and further analyzed in the cloud for aggregation and diagnosis.

The capsule can potentially diagnose a range of gut disorders, from motility disorders, irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD) to liver disease. Please note that the Atmo Gas Capsule is currently only available for use in clinical investigations and is not yet available for sale